sumitomo pharma press release:Stay Up to Date with Our News & Releases
Stay Up to Date with Our News & Releases
Jul.31,2023.SumitomoPharmaandOtsukaAnnounceToplineResultsfromPhase3DIAMOND1andDIAMOND2ClinicalStudiesEvaluatingUlotarontinSchizophrenia.。其他文章還包含有:「PressReleases」、「NewsRoom」、「ForthePress」、「SumitomoPharmaAmericaNewsroom」、「【Jointpressrelease】SumitomoPharmaandPoxel...」、「SumitomoPharmaAnnouncesFDAAcceptanceof...」、「IRNews」、「SumitomoPharmalaysoff400USstaffersassaless...
查看更多 離開網站Press Releases
https://www.sumitomo-pharma.co
Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological ...
News Room
https://www.sumitomo-pharma.co
Information concerning pharmaceuticals and medical devices (including those that are under development) within this News Room are made available solely for ...
For the Press
https://www.sumitomo-pharma.co
Aug. 07, 2024 【Joint press release】Sumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG for the Treatment of ...
Sumitomo Pharma America Newsroom
https://news.us.sumitomo-pharm
Jul 15, 2024. Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia.
【Joint press release】Sumitomo Pharma and Poxel ...
https://www.sumitomo-pharma.co
In October 2017, Sumitomo Pharma concluded a development and commercialization partnership agreement for Japan, Chinese mainland, Taiwan, Korea ...
Sumitomo Pharma Announces FDA Acceptance of ...
https://www.prnewswire.com
Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed or Refractory Acute Myeloid ...
IR News
https://www.sumitomo-pharma.co
Information concerning pharmaceuticals and medical devices (including those that are under development) within this News Room are made available solely for ...
Sumitomo Pharma lays off 400 US staffers as sales slide
https://www.fiercepharma.com
The Japanese drugmaker is letting go of 400 staffers this month. The job cuts at Sumitomo Pharma America come amid a “severe business environment.”
Otsuka and Sumitomo Revise License Agreement
https://otsuka-us.com
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces the revision of the license agreement signed in September 2021 with Sumitomo Pharma Co., Ltd.